isoflurane enhanced synaptic inhibition in VB neurons from both wild-type and Gabra4 -/-mice.
These data indicate an obligatory requirement for α 4 subunit expression in the generation of the isoflurane-activated current. In addition, isoflurane directly activated α 
Introduction
General anesthesia is characterized by a variety of behavioral end-points, including amnesia, analgesia, sedation, blunted autonomic responsiveness, unconsciousness and immobility (Campagna et al., 2003) . In all cases, the dose of general anesthetic required to produce amnesia, sedation and hypnosis is much lower than that required to produce immobility.
For example, the commonly used inhaled anesthetic, isoflurane, prevents voluntary response to spoken commands in human subjects (Dwyer et al., 1992) at concentrations that are only 30-40% of the levels required for immobility in response to a painful stimulus.
In the waking state, the thalamus is involved in the processing and relay of sensory information to the cortex, and is also important in the maintenance of high frequency synchronous oscillatory activity that is associated with attention (Steriade et al., 1993; von Krosigk et al., 1993; Steriade, 2000; Ribary, 2005) . During slow-wave sleep, however, relay neurons in the thalamus are hyperpolarized and generate 1-3Hz (delta wave) activity that entrains neurons in the cortex (Steriade, 2000; Steriade, 2003) .
The thalamo-corticothalamic loop has therefore long been identified as a key target for anesthetic action to induce sedation and hypnosis (Angel, 1993; Alkire et al., 2000; White and Alkire, 2003; Alkire and Miller, 2005) . In vivo, the firing rate of thalamocortical relay cells is strongly suppressed by isoflurane (Detsch et al., 1999) , and these in vivo inhibitory effects of isoflurane can be reversed by local application of the GABA A receptor (GABA A -R) antagonist bicuculline (Vahle-Hinz et al., 2001) , indicating that GABA A -Rs contribute significantly to the effects of the anesthetic on the firing of thalamic neurons, although other mechanisms involving K + conductances have also been proposed to contribute to anesthetic effects in the thalamus (Ries and Puil, 1999) .
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-5-In addition to the "classical" GABA A -Rs that mediate synaptic inhibition, an additional population of GABA A -Rs have recently been demonstrated to occur at extra-synaptic sites in the CNS, and a population of such receptors exists on thalamocortical relay neurons (Belelli et al., 2005; Cope et al., 2005; Jia et al., 2005; Bright et al., 2007) . These extrasynaptic GABA A -Rs, (consisting mainly of α 4 , β 2 , and δ subunits) are persistently activated by low concentrations of GABA and have distinct pharmacological properties that differentiate them from the synaptic GABA A -Rs in relay neurons of the thalamus (which consist mainly of α 1 , β 2 , and γ 2 subunits) (Jia et al., 2005) . GABA-mediated tonic inhibition in thalamic neurons requires expression of the GABA A -R α 4 subunit, as tonic currents are absent in thalamic relay neurons from GABA A -Rα 4 subunit knockout (Gabra4 -/-) mice (Chandra et al., 2006) . The inhibitory function of these extrasynaptic GABA A -Rs has been shown to be enhanced by the novel hypnotic gaboxadol and by the intravenous anesthetic etomidate (Belelli et al., 2005; Cope et al., 2005; Jia et al., 2005) .
In the present study, we investigated the actions of isoflurane on thalamocortical neurons in the mouse ventrobasal (VB) thalamus. We found that isoflurane, at clinically relevant concentrations (25 -250 µM) (Franks and Lieb, 1994) , evoked sustained currents in VB neurons.
These sustained currents were blocked by gabazine, a selective antagonist of GABA A -Rs. In addition, we examined the actions of isoflurane on GABA A -Rs expressed in HEK 293 cells, using subunit compositions chosen to resemble synaptic and extrasynaptic GABA A -Rs found in the thalamus. We found that isoflurane directly activated the "extrasynaptic" α isoflurane-activated current was absent in VB neurons from Gabra4 -/-mice, which do not express extrasynaptic GABA A -Rs (Chandra et al., 2006) . Our data suggest that isoflurane is a potent modulator of extrasynaptic GABA A -Rs in VB neurons.
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Methods

Electrophysiological recordings in brain slices
Experiments were performed in accordance with institutional and federal guidelines.
Mice between 22 and 50 days old (C57BL/6, Gabra4 +/+ and Gabra4 -/-) were anesthetized with halothane and sacrificed. The brains were quickly removed and placed in ice-cold slicing solution, which contained (in mM): 2. MΩ and the change in series resistance was less than 20% over the course of the experiment.
Data were analyzed as described previously (Jia et al., 2005) ; very briefly, off-line analysis was performed using MiniAnalysis 5.5 (Synaptosoft, Decatur, GA), SigmaPlot 6.0 (SPSS, Chicago, GABA alone (I EC20 ) was defined as the control response and isoflurane was then pre-applied for 20s prior to co-application with GABA(EC 20 ) to ensure that isoflurane had reached equilibrium with the receptors. Isoflurane-induced potentiation was calculated as the percentage increase in peak current relative to control. Currents elicited directly during pre-application of isoflurane were measured and normalized to I EC20 in order to quantify the direct activation of GABA A receptors by isoflurane in the absence of GABA. Statistical significance was assessed using a one-way ANOVA with a Dunnett's multiple comparison post-test. Data are presented as mean ± SEM.
Drugs and preparation of volatile anesthetic solutions
GABA (4-aminobutanoic acid), gabazine (4-[6-imino-3-(4-methoxyphenyl) pyridazin-1-yl] butanoic acid hydrobromide) and kynurenic acid (4-oxo-1H-quinoline-2-carboxylic acid)
were purchased from Sigma (St. Louis, MO). Isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane) was obtained from Abbott Laboratories (North Chicago, IL). A stock solution of 10 mM GABA was prepared daily. Isoflurane solutions were prepared by injection of liquid anesthetic with a gas-tight syringe (Hamilton, Reno, NV) into intravenous solution bags containing 100 ml extracellular solution and were used within two hours (Krasowski and Harrison, 2000) . Isoflurane solutions were applied to the brain slice preparations via perfusion through polytetrafluoroethylene tubing; the drug-containing solution was applied to the HEK cells locally using a rapid solution changer. We have previously shown that losses of anesthetic to the air and the tubing using this approach are less than 5% (Krasowski and Harrison, 2000) . α 4 subunit gene knockout mice were generated as previously described (Chandra et al., 2006) . All knockout (Gabra4 -/-) and wild-type (Gabra4 +/+ ) littermates used were age-matched and were on the same genetic background (129X1/S1 x C57BL/6J hybrid; F2-F6 generations).
Experimenters were blind to genotype in all studies.
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Results
Low concentrations of isoflurane enhance tonic inhibition in VB neurons
Voltage-clamp recordings were made in VB relay neurons held at -60 mV using a CsClbased intracellular solution. A low concentration of isoflurane (25 µM) elicited a sustained inward current ( Figure 1A) ; the mean amplitude of this current was 10 ± 2 pA (n = 14). At higher concentrations, isoflurane elicited larger currents (85 µM: 23 ± 3 pA, n = 14; 250 µM: 51 ± 4 pA, n = 17; Figures 1B and C).
We next examined whether the currents induced by isoflurane were mediated by GABA A -Rs. As shown in Figure 2A , 20 µM gabazine, a specific GABA A -R antagonist, not only completely blocked inhibitory synaptic currents (IPSCs), but also blocked the inward current elicited by isoflurane (250 µM), indicating that these isoflurane-activated tonic currents are mediated by GABA A -Rs. The additional outward current induced by the addition of gabazine ( Figure 2A) indicates the presence of a persistent background current in this neuron, consistent with the reports of tonic inhibition in thalamocortical relay neurons (Belelli et al., 2005; Cope et al., 2005; Jia et al., 2005; Chandra et al., 2006; Bright et al., 2007) . Isoflurane is able to directly activate GABA A -Rs (Yang et al., 1992 ; see also Figure 5 ), as well as potentiate the action of GABA at these receptors (Jones and Harrison, 1993 , see also Figure 5 ), and so for the sake of simplicity, we will refer to the sustained current recorded from neurons in brain slices as the "tonic current" or "isoflurane-activated current".
We then performed experiments using a voltage ramp protocol to compare the reversal potential of isoflurane-activated currents (E Iso ) to the Cl -equilibrium potential (E Cl ). Currents induced by a slow ramp voltage command (+40 to -40 mV, 10 seconds) were recorded before and after the perfusion of 250 µM isoflurane, and E Iso was calculated from the subtracted traces This article has not been copyedited and formatted. The final version may differ from this version. JPET #134569
-11-as shown in Figure 2B ; E Iso was 5 ± 1 mV (n = 6), which is very close to the predicted E Cl (2.1 mV), calculated using the Nernst equation. These results support our interpretation that isoflurane-induced currents arise via the enhancement of a chloride conductance mediated by GABA A -Rs.
Isoflurane prolongs the decay time of IPSCs
We also examined the effects of isoflurane on synaptic GABA A -Rs in the thalamus. In thalamic VB neurons, synaptic GABA A -Rs consist primarily of α 1 , β 2 , and γ 2 subunits (Jia et al., 2005) . Spontaneous IPSCs were readily observed in VB neurons and were completely blocked by gabazine (Figure 2A ). Isoflurane (25 -250 µM) had no effect on either the amplitude or frequency of these IPSCs (Figure 3 ). Low concentrations of isoflurane (25 and 85 µM), isoflurane had little to no effect on the decay time of IPSCs (% change: 25 µM, 4 ± 4%, n = 10; 85 µM, 28 ± 6%, n = 10), but a higher concentration of 250 µM isoflurane significantly increased IPSC decay time (133 ± 12%, n = 10). Only the higher concentrations of isoflurane (85-250 µM), therefore, prolong IPSCs mediated by synaptic GABA A -Rs in VB relay neurons, and these findings are completely consistent with observations made in hippocampal neurons (Jones and Harrison, 1993; Banks and Pearce, 1999; Nishikawa and MacIver, 2001; Caraiscos et al., 2004; Verbny et al., 2005) .
Isoflurane decreases the excitability of VB neurons
From a resting membrane potential of about -75 mV, most VB neurons in our recordings displayed "burst" firing in response to depolarizing current injection (Llinãs and Jahnsen, 1982) .
In order to facilitate measurements of firing rate, we therefore depolarized the membrane -12-potential to about -60 mV by constant current injection. At this membrane potential, VB neurons were generally silent but displayed sustained action potential (AP) firing in response to injection of depolarizing current. The amplitude of the current step (500 ms duration) was adjusted to induce ~10 APs ( Figure 4A ), corresponding to a firing frequency of ~20 Hz, and we then compared the numbers of APs evoked by depolarizing current steps before and after isoflurane application. Isoflurane (25 µM) significantly reduced the number of evoked APs, from 9.5 ± 1.0 to 7.5 ± 1.0 (p < 0.01, n = 6). In addition to the effect on spike firing, isoflurane (25 µM) also decreased the membrane input resistance (R m ) to 90 ± 2% of control (p < 0.01, n = 6). Figure 5C ).
Isoflurane directly activates GABA
In the presence of isoflurane, the peak current observed in response to GABA is actually the sum of two components, I Direct (i.e., the current induced by isoflurane alone, due to direct receptor activation) and I GABAEC20+ISO (i.e., the isoflurane-potentiated GABA-evoked current). In a more detailed analysis, we compared these two currents in α Figure 6B ). Note that these data illustrate the potentiating effect of isoflurane, calculated by subtracting I Direct ( Figure 6A ) from the total current ( Figure 5C ).
Because some of the isoflurane currents were small in amplitude (~10 pA), we decided to test the possibility that the currents were influenced by the change of solutions and the associated movement artifacts. We therefore used the same protocol, but omitted the isoflurane. Under these test conditions, when switching from one stream of saline to another, there was no significant enhancement of the GABA response (α 1 β 2 γ 2s : 0 ± 10%, n = 5; α In a final set of experiments, we used a knock-out mouse strain to determine whether extrasynaptic GABA A -Rs are required for the generation of isoflurane-induced currents in the thalamus. We have previously demonstrated that extrasynaptic GABA A -Rs are absent in thalamic relay neurons from Gabra4 -/-mice (Chandra et al., 2006) . No significant isofluraneevoked currents were detected in VB neurons from Gabra4 -/-mice (25 µM: 0 ± 1 pA, n = 10; 85 µM: 0 ± 1 pA, n = 12; 250 µM: 1 ± 1 pA, n = 11). In contrast, wild-type neurons showed measurable isoflurane-evoked currents (25 µM: 8 ± 2 pA, n = 8; 85 µM: 17 ± 3 pA, n = 8; 250
µM: 44 ± 4 pA, n = 9), which were comparable to isoflurane-evoked currents recorded from standard C57BL/6 mice ( Figure 7) . This difference between the genotypes was highly significant (p < 0.001 at all three concentrations of isoflurane). In contrast, we found that the modulation of IPSCs in VB neurons by isoflurane was similar in wild-type and α 4 knockout mice. As shown in Figure 7C , isoflurane had a comparable effect on the decay time of IPSCs recorded in VB neurons from wild-type and Gabar4 -/-mice. IPSC decay times (in ms) in the absence or presence of isoflurane (at the specified concentration) were (WT vs. KO): control: 15 ± 1 vs. 14 ± 1; 25 µ M, 16 ± 2 vs. 15 ± 1; 85µM, 19 ± 1 vs. 19 ± 2; 250 µ M, 33 ± 3 vs. 31 ± 3. These results are consistent with the hypothesis that extrasynaptic (and not synaptic) GABA A -Rs mediate the isoflurane-evoked tonic current in thalamic neurons.
This article has not been copyedited and formatted. The final version may differ from this version. (Jones and Harrison, 1993; Krasowski et al., 1998; Banks and Pearce, 1999; Krasowski and Harrison, 2000; Li and Pearce, 2000; Nishikawa and MacIver, 2001; Nishikawa and Harrison, 2003; Hemmings et al., 2005) . In the present study, we found that isoflurane (25 -250 µ M) induced sustained currents in thalamic relay neurons and that this was completely dependent on the presence of extrasynaptic GABA A -Rs (α 4 β 2 δ subtype).
Recordings from α General anesthesia in mammals is a complex phenomenon, involving a combination of desirable effects such as amnesia, hypnosis and immobility (Campagna et al., 2003) . Although immobilization is commonly used as a measure of anesthetic potency (Hemmings et al., 2005) , 3-fold lower concentrations are required for sedation and hypnosis (Dwyer et al., 1992) .
GABA A -Rs may not be involved in the immobilizing action of inhaled anesthetics, which seems to occur at the level of the spinal cord, and is resistant to GABA antagonists (Sonner et al., 2003) , but there is strong evidence that GABA A -Rs are involved in the sedation and hypnosis induced by many general anesthetics (reviewed by Hemmings et al., 2005) .
The thalamus relays sensory information to the appropriate modality-specific areas in the sensory cortex, and also participates in the transitions between waking and sleep states (Saper et al., 2001; Steriade, 2003) . The thalamus is therefore a potential target for the sedative and A K + conductance mechanism has been implicated in the inhibitory actions of isoflurane in the thalamus in vitro (Ries and Puil, 1999b; Ries and Puil, 1999a) , but in other studies the effect of isoflurane to inhibit spike firing induced by a mechanical-stimulus in the thalamus in vivo is blocked by local application of the GABA A -R antagonist bicuculline (Vahle-Hinz et al., 2001 ). In the present study, we demonstrate that tonic currents activated by isoflurane in thalamic neurons in vitro are mediated by GABA A -Rs, because the isoflurane-induced currents were totally blocked by a specific GABA A -R antagonist, gabazine. In addition, the reversal potential of isoflurane-induced currents (E Iso ) is close to the calculated equilibrium potential for chloride ions (E Cl ) in our experiments, and far from E K .
Extrasynaptic GABA A -Rs and tonic inhibition have been observed in the thalamus, hippocampus, dentate gyrus, cortex and cerebellum (Brickley et al., 1996; Nusser and Mody, 2002; Jia et al., 2005; Keros and Hablitz, 2005) . The presence of a low concentration of GABA in the extracellular space leads to persistent activation of the extrasynaptic GABA A -Rs, and the resulting tonic inhibition regulates the excitability of individual neurons and the activity of neural networks (Mody and Pearce, 2004; Semyanov et al., 2004; Farrant and Nusser, 2005; This article has not been copyedited and formatted. The final version may differ from this version. -17-et al., 2007) . In the thalamus, δ -subunit containing extrasynaptic GABA A -Rs appear to be a common target for a variety of sedative and hypnotic agents, including gaboxadol (THIP; 4, 5, 6, pyridin-3-ol) (Belelli et al., 2005; Cope et al., 2005; Jia et al., 2005) and tetrahydrodeoxycorticosterone (THDOC) (Cope et al., 2005) . Several labs also report that extrasynaptic GABA A -Rs containing the δ -subunit are sensitive to low concentrations of ethanol (Mody et al., 2007; Olsen et al., 2007; Santhakumar et al., 2007; Smith and Gong, 2007;  but see : Borghese and Harris, 2007; Botta et al., 2007) .
Of note, not all extrasynaptic GABA A -Rs contain δ subunits; in hippocampal CA1 pyramidal neurons, for example, one population of extrasynaptic GABA A -Rs contains the α 5 subunit (Caraiscos et al., 2004) . Like extrasynaptic receptors containing δ subunits, α 5 -subunit containing GABA A -Rs are sensitive to a spectrum of anesthetic agents. At the same concentration of isoflurane as used in the present study, Caraiscos and colleagues observed that 25 µ M isoflurane potentiated the tonic current in cultured hippocampal pyramidal neurons obtained from wild-type, but not α 5 -subunit knockout, mice (Caraiscos et al., 2004) . In addition, the intravenous anesthetic etomidate was shown to potentiate tonic currents recorded in cultured hippocampal pyramidal neurons expressing the GABA A -R α 5 -subunit. In this case, the amnestic, and not sedative-hypnotic, effect of the drug is dependent on α 5 -subunit expression (Cheng et al., 2006) . These studies suggest that extrasynaptic GABA A -Rs are a common molecular target for CNS depressants (Orser, 2006) .
In the thalamus, extrasynaptic GABA A -Rs that contain the δ subunit also seem to require inclusion of the GABA A -R α 4 subunit as tonic currents are absent in relay neurons from GABA A -R α 4 subunit knockout (Gabra4 -/-) mice (Chandra et al., 2006) . Our experiments on thalamic This article has not been copyedited and formatted. The final version may differ from this version. (Krasowski et al., 1998; Krasowski and Harrison, 2000; Raines et al., 2003) .
In conclusion, we show that extrasynaptic GABA A -Rs in the thalamus are potently activated by isoflurane. Since the thalamus plays a critically important role in both sensory processing and sleep regulation, we suggest that the sedative and hypnotic actions of isoflurane at sub-anesthetic concentrations may be mediated in part through this population of receptors.
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C, Pooled data illustrating the effects of isoflurane on IPSC parameters. The low (25 and 85 µM)
concentrations of isoflurane have no effect on any IPSC parameter (decay time: control 13.8 ± 1.4 ms; 25 µM isoflurane, 14.1± 1.2ms; n = 10; 85 µM, 17.0 ± 1.3 ms, n = 10) while 250 µM isoflurane significantly increased the decay time to 31.0 ± 2.5 ms (n = 10, *** p < 0.001, oneway ANOVA). B, Pooled data shows that isoflurane (25 µM) reduces the firing rate of VB neurons to 79 ± 4% of control (**: p < 0.01, n = 6); isoflurane also reduced R m from 298 ± 50 MΩ to 272 ± 49 MΩ (**: p < 0.01). 
